Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,207 | 526 | 98.1% |
| Education | $119.20 | 13 | 1.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $774.20 | 70 | $0 (2024) |
| PFIZER INC. | $638.25 | 87 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $562.19 | 26 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $504.18 | 55 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $481.78 | 44 | $0 (2023) |
| Amgen Inc. | $440.09 | 37 | $0 (2023) |
| Astellas Pharma US Inc | $432.69 | 27 | $0 (2024) |
| Lilly USA, LLC | $339.41 | 28 | $0 (2024) |
| ABBVIE INC. | $320.63 | 18 | $0 (2024) |
| Novo Nordisk Inc | $312.43 | 25 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $255.36 | 13 | GlaxoSmithKline, LLC. ($98.09) |
| 2023 | $558.83 | 34 | AbbVie Inc. ($185.90) |
| 2022 | $303.60 | 16 | E.R. Squibb & Sons, L.L.C. ($60.21) |
| 2020 | $108.46 | 8 | GlaxoSmithKline, LLC. ($43.15) |
| 2019 | $1,618 | 138 | PFIZER INC. ($183.29) |
| 2018 | $1,839 | 172 | AstraZeneca Pharmaceuticals LP ($213.30) |
| 2017 | $1,643 | 158 | PFIZER INC. ($200.23) |
All Payment Transactions
539 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/26/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: RESPIRATORY | ||||||
| 09/24/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $20.52 | General |
| Category: NEUROSCIENCE | ||||||
| 08/15/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $20.90 | General |
| Category: NEUROSCIENCE | ||||||
| 08/08/2024 | GlaxoSmithKline, LLC. | BEXSERO (Biological) | Food and Beverage | In-kind items and services | $22.99 | General |
| Category: VACCINES | ||||||
| 08/06/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/13/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $32.42 | General |
| Category: NEUROSCIENCE | ||||||
| 04/02/2024 | Biogen, Inc. | AVONEX (Biological), PLEGRIDY, VUMERITY | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: Neurology | ||||||
| 03/26/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: Biological | ||||||
| 03/07/2024 | GlaxoSmithKline, LLC. | BEXSERO (Biological) | Food and Beverage | In-kind items and services | $21.77 | General |
| Category: VACCINES | ||||||
| 02/22/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: Diabetes | ||||||
| 02/15/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.33 | General |
| Category: RESPIRATORY | ||||||
| 01/23/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: PAIN | ||||||
| 01/09/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), BEXSERO, AREXVY | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: VACCINES | ||||||
| 11/20/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: Biological | ||||||
| 10/27/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $5.00 | General |
| Category: VACCINES | ||||||
| 10/19/2023 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $13.80 | General |
| Category: Durable Pump | ||||||
| 10/17/2023 | AbbVie Inc. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $20.37 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/12/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $19.47 | General |
| Category: Cardiovascular | ||||||
| 10/10/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.31 | General |
| Category: RESPIRATORY | ||||||
| 09/19/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: PAIN | ||||||
| 09/05/2023 | GlaxoSmithKline, LLC. | BEXSERO (Biological) | Food and Beverage | In-kind items and services | $22.39 | General |
| Category: VACCINES | ||||||
| 08/22/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $20.74 | General |
| Category: RESPIRATORY | ||||||
| 08/17/2023 | PFIZER INC. | PAXLOVID (Drug), NURTEC ODT, ZAVZPRET | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 08/09/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $19.10 | General |
| Category: VACCINES | ||||||
| 08/03/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.18 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,364 | 5,296 | $364,640 | $222,049 |
| 2022 | 18 | 1,244 | 3,683 | $264,458 | $157,145 |
| 2021 | 19 | 1,154 | 3,649 | $247,919 | $147,612 |
| 2020 | 19 | 1,284 | 3,773 | $249,455 | $134,423 |
All Medicare Procedures & Services
81 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 185 | 964 | $72,300 | $42,334 | 58.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 209 | 416 | $66,560 | $33,607 | 50.5% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 21 | 1,800 | $44,550 | $33,032 | 74.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 203 | 203 | $30,450 | $24,999 | 82.1% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 128 | 589 | $32,395 | $20,567 | 63.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 193 | 300 | $33,000 | $14,925 | 45.2% |
| 99489 | Complex chronic care management services for two or more chronic conditions, each additional 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 27 | 259 | $20,720 | $13,802 | 66.6% |
| 99484 | Care management services for behavioral health conditions, 20 minutes or more clinical staff time directed by health care professional | Office | 2023 | 57 | 294 | $16,170 | $9,105 | 56.3% |
| 99487 | Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 31 | 67 | $10,050 | $6,631 | 66.0% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 26 | 26 | $9,100 | $5,285 | 58.1% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 58 | 59 | $5,310 | $4,434 | 83.5% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 17 | 17 | $5,300 | $4,214 | 79.5% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 24 | 24 | $5,760 | $3,721 | 64.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 63 | 64 | $2,880 | $1,885 | 65.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 21 | 23 | $2,553 | $1,062 | 41.6% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 15 | 19 | $2,530 | $874.45 | 34.6% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 16 | 17 | $1,700 | $593.70 | 34.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 17 | 17 | $765.00 | $441.75 | 57.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 26 | 39 | $1,560 | $374.85 | 24.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 12 | 12 | $117.00 | $99.26 | 84.8% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 15 | 87 | $870.00 | $62.73 | 7.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 223 | 464 | $74,240 | $36,911 | 49.7% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 20 | 1,740 | $43,065 | $28,813 | 66.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 212 | 212 | $31,800 | $26,725 | 84.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 214 | 346 | $38,109 | $17,215 | 45.2% |
About Dr. David Bresticker, MD
Dr. David Bresticker, MD is a Family Medicine healthcare provider based in Williamsport, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1376582841.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Bresticker, MD has received a total of $6,326 in payments from pharmaceutical and medical device companies, with $255.36 received in 2024. These payments were reported across 539 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($6,207).
As a Medicare-enrolled provider, Bresticker has provided services to 5,046 Medicare beneficiaries, totaling 16,401 services with total Medicare billing of $661,229. Data is available for 4 years (2020–2023), covering 81 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Williamsport, PA
- Active Since 06/06/2006
- Last Updated 04/13/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1376582841
Products in Payments
- FARXIGA (Drug) $436.07
- XARELTO (Drug) $358.63
- MYRBETRIQ (Drug) $259.61
- CHANTIX (Drug) $259.23
- TRELEGY ELLIPTA (Drug) $251.51
- JARDIANCE (Drug) $183.99
- ELIQUIS (Drug) $179.92
- Prolia (Biological) $178.71
- ENTRESTO (Drug) $172.64
- VRAYLAR (Drug) $168.19
- INVOKANA (Drug) $145.55
- PREVNAR - 13 (Biological) $134.36
- TRULICITY (Drug) $132.48
- TRADJENTA (Drug) $131.30
- Myrbetriq (Drug) $125.20
- Trintellix (Drug) $123.10
- TOUJEO (Drug) $110.48
- ANORO (Drug) $108.65
- BREO (Drug) $107.17
- STIOLTO RESPIMAT (Drug) $107.07
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Williamsport
Karen C Iccarelli, M.d, M.D
Family Medicine — Payments: $29,012
Thomas Wallace, Md, MD
Family Medicine — Payments: $11,498
Frank Mazzotta, Do, DO
Family Medicine — Payments: $7,667
Dr. Kenneth Durrwachter, Md, MD
Family Medicine — Payments: $4,982
Mona Chang, Md, MD
Family Medicine — Payments: $2,104
Jeniece Cooper, Md, MD
Family Medicine — Payments: $2,084